SpineSix consists of a motorized treatment table that is controlled by an integral computer. The system is operated by means of 12-inch Color LCD touch screen that displays treatment time, positioning and magnitude and direction of motion. There are eight fully customizable Patient Protocol settings for commonly used treatment settings. The SpineSix BioMotion Spinal System is intended to reproduce normal spine mechanics and physiological movements so that a patient can comfortably and safely experience functional range of motion in a non-weight-bearing environment.
Publicado el 26 de diciembre de 2012 · Inicio del retiro: 12 de noviembre de 2012
Resumen
FDA registra el retiro Z-0571-2013 de dispositivos médicos de Clase II, publicado el 26 de diciembre de 2012 e iniciado el 12 de noviembre de 2012. Empresa responsable: BioMotion Medical Systems, LLC; Estado: Finalizado; Cantidad reportada: 28 units; Lote: serial numbers: 1001 through 1054. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
BioMotion is issuing a field correction for all models of the SpineSix (SpineSix01 and SpineSix02; serial numbers 1001 through 1054) to rectify all regulatory deficiencies involving the former owners of the SpineSix product and concurrently preparing the submission of a 510(k) application in order to receive premarket clearance for SpineSix.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- BioMotion Medical Systems, LLC
- Distribuidor
- Distributed in Florida, Georgia, Tennessee, New Jersey, New York, Pennsylvania, and Wisconsin.
- Lote
- serial numbers: 1001 through 1054
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDABD Phoenix PMIC-108 Panels, Catalog number 448418, labeled in part ***Becton, Dickinson and Company 7 Loveton26 de diciembre de 2012
- FDAThe Access hLH assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative26 de diciembre de 2012
- FDAPinnacle Cancellous Screw Packaging: Product is housed within a polyurethane protector; this is placed inside26 de diciembre de 2012
- FDASOL SYS 8IN CALCAR SZ12 Packaging: Product is packed within a poly protector, with protection added as needed26 de diciembre de 2012
- FDAMedline Angio Drape Pack Radiology-LF; a sterile custom single patient prescription procedure pack, including26 de diciembre de 2012
- FDASOL SYS F 8 CALC 13.5MM LG Packaging: Product is packed within a poly protector, with protection added as26 de diciembre de 2012
Preguntas sobre este retiro
¿SpineSix consists of a motorized treatment table that is controlled by an integral computer. The system is operated by means of 12-inch Color LCD touch screen that displays treatment time, positioning and magnitude and direction of motion. There are eight fully customizable Patient Protocol settings for commonly used treatment settings. The SpineSix BioMotion Spinal System is intended to reproduce normal spine mechanics and physiological movements so that a patient can comfortably and safely experience functional range of motion in a non-weight-bearing environment. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0571-2013 el 26 de diciembre de 2012. Peligro reportado: BioMotion is issuing a field correction for all models of the SpineSix (SpineSix01 and SpineSix02; serial numbers 1001 through 1054) to rectify all regulatory deficiencies involving the former owners of the SpineSix product and concurrently preparing the submission of a 510(k) application in order to receive premarket clearance for SpineSix.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter